Evidence map›Paper›PMID 41828123›Full record

ArticleMaterials (Basel, Switzerland)2026

Development of a Soda-Lime Glass Feedstock for Injection Molding.

Martin Zürn, Steffen Antusch, Dorit Nötzel, Annika Schrage, Heinz Walter, Thomas Hanemann

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Martin ZürnInstitute for Applied Materials, Karlsruhe Institute of Technology, Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany.
Steffen AntuschInstitute for Applied Materials, Karlsruhe Institute of Technology, Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany.ORCID 0000-0003-2254-4511
Dorit NötzelInstitute for Applied Materials, Karlsruhe Institute of Technology, Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany.ORCID 0009-0001-1489-774X
Annika SchrageInstitute for Applied Materials, Karlsruhe Institute of Technology, Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany.
Heinz WalterInstitute for Applied Materials, Karlsruhe Institute of Technology, Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany.
Thomas HanemannInstitute for Applied Materials, Karlsruhe Institute of Technology, Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany.ORCID 0000-0002-8641-2094

Funding

Deutsche Forschungsgemeinschaft HA 1924-1/2 and HA1924/35-1
6 · The paper itself

Abstract

Injection molding has been used for many years in the fabrication of thermoplastic parts with different complexities. With metal and ceramic injection molding, it is possible to realize at the end of the related process chain sintered metal and ceramic parts. Parts made from glass are rather seldom realized applying powder technology methods. This work describes the production of devices made from a commercial soda-lime glass applying the process chain of powder injection molding, covering the individual process steps like compounding, shaping, debinding, and sintering. In the first step, a binder consisting of polyethylene glycol (PEG) with different average molecular masses (4000, 8000, and 20,000 g/mol), polyvinyl butyral (PVB), and stearic acid (SA) were used for compounding new feedstocks with a solid load of 55 Vol% and 60 Vol%. As filler, a soda-lime glass with an average particle size of 6.1 µm, an almost symmetrical particle size distribution, a specific surface area of 0.78 m

Indexed as

glass injection moldingPEG/PVB-based bindersoda-lime glass molding

Identifiers

PMID41828123
PMCPMC12985438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.